Pulse-Echo Ultrasound Bone Density Measurement

This policy addresses pulse‑echo ultrasound bone density measurement (e.g., the Bindex handheld tibial pulse‑echo device) proposed for screening, diagnosis, or monitoring of osteoporosis. It states no covered indications—the procedure is considered experimental/investigational and not covered for postmenopausal women or other at‑risk populations—and notes major limitations including measurement confined to the proximal tibia, requirement for proprietary hardware/software and trained operators, limited validation (primarily in white European postmenopausal women), and that it is not a substitute for central DXA.

"None — pulse-echo ultrasound bone density measurement is considered experimental, investigational and/or unproven and has no covered indications in this policy."

Sign up to see full coverage criteria, indications, and limitations.